NCT01184885 2025-05-04
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
Thomas Jefferson University
Thomas Jefferson University
The University of Texas Health Science Center at San Antonio
The University of Texas Health Science Center at San Antonio
University of Chicago
Abramson Cancer Center at Penn Medicine